FDA advisors voted against MDMA therapy – researchers are still fighting for it

> A primary issue was functional unblinding, or the ability of participants to tell whether they received a placebo or active drug... More than 90% of people in the MDMA group and 75% in the placebo group correctly guessed their treatment arm in the second Phase 3 trial.

Why are you telling the control group they are going to get potentially get high? Why didn't you pick a much lower dosage?

I think there is a treatment here, I dont think this vote was wrong. Do some better science on this and ask again later.